licensedpsychedelics
Find a provider

Editorial policy

How we research, write and verify

Last updated 2026-04-19

LicensedPsychedelics is a directory and patient-guidance publication covering US psychedelic therapy. Every guide on this site is written and maintained by the LicensedPsychedelics editorial team, under the standards below.

01

Primary sources first

Every factual claim links to a government document, peer-reviewed paper, or official agency page. No opinion blogs as load-bearing sources.

02

Dated and revisable

Every guide carries a published and updated date. When the underlying rule changes, we revise the guide and note the change.

03

Patient guidance, not medical advice

We explain policies and clinical frameworks in plain English so patients can talk to their own clinicians. We don't diagnose or prescribe.

Who writes these guides

Every article on LicensedPsychedelics is attributed to the LicensedPsychedelics Editorialteam, not to an individual author. This is deliberate. Psychedelic medicine is a fast-moving regulatory and clinical space where policies, trial results, and access pathways change month to month. Keeping a single team byline lets us update any article without having to re-anchor the voice around a specific person, and it makes clear that the site’s credibility rests on our sourcing process, not on claimed individual credentials.

When an article benefits from specific clinical or regulatory expertise beyond the editorial team’s background, we cite the primary source (a peer-reviewed paper, an FDA letter, a clinical trial record, a state policy document, a named clinician’s published work) inline. We don’t invent fictional experts, and we don’t attribute opinions to named authors who didn’t write them.

Sourcing standards

  • 1

    Federal and regulatory

    FDA press releases, Federal Register rulemakings, DEA scheduling letters, White House fact sheets, congressional bill text, and published agency guidance documents. We link to the .gov source, not a summary.

  • 2

    State programs

    Oregon Psilocybin Services (OHA), Colorado Natural Medicine Division (DORA), and analogous agencies in states with active or pending programs. State administrative code where it exists.

  • 3

    Clinical research

    Peer-reviewed journals (Nature Medicine, JAMA Psychiatry, American Journal of Psychiatry, etc.), ClinicalTrials.gov registration entries, and published conference abstracts. We don't cite preprints as if they were peer-reviewed.

  • 4

    Professional societies

    ASKP3 (American Society of Ketamine Physicians, Psychotherapists and Practitioners), AMA, APA clinical practice guidelines, and specialty-board position statements where relevant to a clinical claim.

  • 5

    Directory verification

    NPI Registry, FDA REMS site directory, state medical boards, and OHA/DORA licensee lists. Every published provider is re-checked against the issuing authority on a rolling 30-day cycle.

Update cadence

Every article carries a visible “Updated” date. When an article is materially revised (new federal action, new FDA decision, new state program opening), the update date is refreshed and the change is noted in the body.

Our review cadence varies by topic:

  • Federal policy and news: reviewed within 48 hours of any relevant White House, FDA, DEA, or HHS action.
  • State programs (Oregon OPS, Colorado DORA, pending initiatives): reviewed quarterly or when the state agency publishes a rule change.
  • Insurance and clinical guidance (Spravato coverage, modality comparisons, clinic-vetting): reviewed every six months against payer policy bulletins and published clinical literature.
  • Directory listings: every published provider is re-verified against the issuing authority on a rolling 30-day cycle.

This is patient guidance, not medical advice

Nothing on this site diagnoses, treats, or prescribes. We publish plain-English explanations of policies, programs, and clinical frameworks so patients can have better conversations with their own licensed clinicians. Always consult a licensed prescriber before making any treatment decision. If you are in psychiatric crisis, call 988(US Suicide & Crisis Lifeline).

Corrections

If you find an error - a broken source link, an outdated policy description, a misstated clinical fact - email us at verify@licensedpsychedelics.com. Include the URL of the page, the specific claim you’re disputing, and (if possible) the primary source you believe is correct.

We respond to every correction within 72 hours. Confirmed errors are fixed inline, and the article’s update date is refreshed. Substantive corrections (not typos) are noted in the body.

Conflict of interest

LicensedPsychedelics earns revenue from verified provider listings and, in the future, from clinic subscription tiers for featured placement. We do not take payment to publish a clinic, and paid placement is always marked as Featuredon the listing card. Our editorial content is not influenced by advertising relationships, and we don’t accept free products, treatment subsidies, or sponsored-post arrangements from drug sponsors, clinics, or therapy platforms.

If a future partnership would create a meaningful conflict (for example, equity in a listed provider), it will be disclosed on this page and on any article that covers the relevant organization.